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Abstract
Although cancer patients may incur a wide range of cancer-related out-of-pocket costs and experience reduced
income, the consequences of this financial burden are poorly understood. We investigated: financial adjustments
needed to cope with the cancer-related financial burden; financial distress (defined as a reaction to the state of
personal finances); and factors that increase risk of financial difficulties. Two sets of semi-structured face-to-face
interviews were conducted with 20 patients with breast, lung and prostate cancer and 21 hospital-based oncology
social workers (OSWs) in Ireland, which has a mixed public-private healthcare system. Participants were asked
about: strategies to cope with the cancer-related financial burden; the impact of the financial burden on the family
budget, other aspects of daily life, and wellbeing. OSWs were also asked about patient groups they thought were
more likely to experience financial difficulties. The two interview sets were analysed separately using a thematic
approach. Financial adjustments included: using savings; borrowing money; relying on family and friends for direct
and indirect financial help; and cutting back on household spending. Financial distress was common. Financial
difficulties were more likely for patients who were older or younger, working at diagnosis, lacked social support, had
dependent children, had low income or had few savings. These issues often interacted with one another. As has
been seen in predominantly publically and predominantly privately-funded healthcare settings, a complex mixed
public-private healthcare system does not always provide adequate financial protection post-cancer. Our findings
highlight the need for a broader set of metrics to measure the financial impact of cancer (and to assess financial
protection in health more generally); these should include: out-of-pocket direct medical and non-medical costs;
changes in income; financial adjustments (including financial coping strategies and household consumption patterns);
and financial distress. In the interim, cancer patients require financial information and advice intermittently post
diagnosis.
Citation: Timmons A, Gooberman-Hill R, Sharp L (2013) "It's at a Time in Your Life When You Are Most Vulnerable": A Qualitative Exploration of the
Financial Impact of a Cancer Diagnosis and Implications for Financial Protection in Health. PLoS ONE 8(11): e77549. doi:10.1371/journal.pone.0077549
Editor: Hiromu Suzuki, Sapporo Medical University, Japan
Received May 8, 2013; Accepted September 10, 2013; Published November 11, 2013
Copyright: © 2013 Timmons et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was funded by the Irish Cancer Society (ICS). Representatives of the ICS were on the study advisory group. The funders had no role
in data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have the following interests: A project grant was awarded to the National Cancer Registry from Sanofi-Aventis,
2010-2012, for research on comorbidity in prostate cancer (PI: L Sharp). There are no patents, products in development or marketed products to declare.
This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
* E-mail: a.timmons@ncri.ie
Introduction
There is a growing awareness of the financial impact that
cancer can have both on newly diagnosed patients and those
living with the condition [1,2]. Patients incur a wide range of
direct medical and non-medical out-of-pocket costs, all of which
have been documented in diverse healthcare settings [1–9]
and, while the amounts incurred vary, and not all patients
experience all costs, the total out-of-pocket costs that any one
patient experiences may be substantial, either in absolute
terms or in relation to their ability to meet them. Ability to meet
extra costs is likely to depend on several factors notably
income, and changes in this post-diagnosis have also been
documented in diverse settings [10–14]. Individual or family
circumstances at diagnosis (including financial commitments
such as rent, mortgage, or loan payments, savings and other
assets) are also important, as is the financial protection
available (i.e. how far people are protected from the financial
consequences of illness) from the legal, and health and social
welfare systems. It has been noted that most health systems
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fail to offer citizens adequate financial protection because of
insufficient financial risk pooling and prepayment mechanisms
[15]; in general, in countries where out-of-pocket payments
comprise a greater share of health funding, financial protection
is worse.
Given the inadequacies of health-related financial protection
it seems likely that some cancer patients may have to make
financial adjustments to cope with their altered financial
situation post-diagnosis. Furthermore, these financial
adjustments may result in financial distress, which is defined as
a reaction to the state of personal finances [16] resulting from
one or more stressors or negative financial events [17]. Since
financial distress is a subjective experience, individuals in the
same financial situation may perceive different levels of this
type of distress. Cancer-related financial adjustments and
financial distress have received little attention, in part due to
the fact that studies have focussed on particular aspects of the
financial or economic impact such as specific out-of-pocket
costs or impact on employment and income [18,19]. The lack of
agreement on what is meant by, or should be included in,
assessments of financial impact and standardised quantitative
instruments to assess this has further delayed progress in this
area [18].
Similar limitations have been highlighted in the broader area
of financial protection in health.
Conventional frameworks for analysis focus on two financial
protection indicators relating to the extent to which health
payments are “catastrophic” (above a threshold percentage of
household equivalent income) or “impoverishing” (pushing a
household below the poverty line). Critics of these frameworks
suggest that the measures of the consequences of inadequate
financial protection are too narrow and are hence likely to
underestimate the adverse consequences of inadequate
financial protection [20]. Moreover, because these metrics are
based on self-reported out-of-pocket medical expenditure, they
effectively ignore the fact that poorer individuals often cannot
afford to use health services and report very low or no health
spending and are therefore (incorrectly) considered to be
“protected” [15].
To date, the limited research on the financial impact of
cancer has been conducted in countries with either a great
reliance on private healthcare and a libertarian ideology (e.g.
the USA which also has a small public system for those who
can’t pay for private healthcare), or more publically-funded
healthcare and an egalitarian ideology (e.g. Canada or the UK,
where a small private system also functions) [2,4]. In most
countries a mixture of libertarian and egalitarian systems
operate [21], but little is known about the financial impact of
cancer in such settings. The Irish system provides an
interesting example. It has a complex structure and financing:
both libertarian and egalitarian principles operate for different
services and different individuals [21].
Qualitative methods have previously proved valuable for
exploring and improving understanding of cancer patients’
experiences [4,6,22,23]. We therefore undertook qualitative
interviews with cancer patients and key informants to
investigate financial adjustments and financial distress in
Ireland. This article reports some of the findings of a broader
investigation of the financial impact of a cancer diagnosis for
patients and their families. The specific aims of this part of the
study were to explore: 1. the financial adjustments needed by
patients to cope with their financial situation after a cancer
diagnosis and 2. the impact of these on financial distress or
well-being.
Methods
Setting
In Ireland, free publicly-funded healthcare is available to
citizens who possess a “medical card”. At the time of the study,
medical card eligibility was means-tested (To qualify for a
medical card or GP visit card an individual’s weekly income
must be below a certain figure for their family size. Cash
income, savings, investments and property (except for their
own home) are taken into account in the means test) for those
aged <70 and universal for those aged ≥70; 30% of the
population had a card [24]. Individuals without a medical card
make co-payments for primary care and outpatient visits, and
public hospital inpatient stays and pay full costs for prescription
medications up to a maximum cost of €85/month with drug
payment scheme. Around half the population have private
medical insurance [25]; plans typically cover inpatient stays,
but may not cover outpatient or primary care costs.
Approximately 25% of the population have neither a medical
card nor private health insurance, and approximately 5% have
both. Employers are not legally obliged to provide sick pay, nor
is there any protection against dismissal from work due to
lengthy sickness absence (e.g. due to cancer). Ireland has a
complex entitlement system: those who do not receive sick pay
are eligible for statutory illness benefit if they have paid enough
social insurance contributions, otherwise they can apply for
other means-tested payments.
Subjects and recruitment
Two groups of subjects were interviewed: people diagnosed
with primary breast, prostate or lung cancer and hospital-based
oncology social workers (OSWs). OSWs frequently provide
patients with advice and assistance regarding financial matters
(although this is not formally part of their remit), and so were
considered key informants who could contribute expert
knowledge of, and valuable insight into, the financial impact of
cancer on patients and families. All 24 OSWs who worked with
patients with breast, prostate or lung cancer were invited to
participate. Patients were eligible if they were: aged ≥18; post-
initial treatment; and had reported that they were experiencing
“extra costs” or “financial difficulties” because of their cancer to
a health professional (i.e. financial difficulties or extra costs
were self-defined by patients). Patients receiving palliative care
were excluded since their experiences of costs may be
substantially different to those of other patients. Breast and
prostate cancer are the most commonly diagnosed cancers in
females and males respectively and lung cancer is the third
most common cancer in both sexes. These cancers provided
diversity in the sample and ensured that we could explore the
experiences of patients: of both sexes; of varied ages and
hence varied family circumstances and employment status;
Financial Impact of Cancer
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and who had a mixture of prognoses and treatment patterns.
Moreover, since lung cancer is inversely related to social class
and breast and prostate cancer risk is higher in the higher
social classes [26], these sites provided diversity with respect
to socio-economic circumstances. The interviewer (AT)
collaborated with participating OSWs and oncology nurses to
identify a purposive patient sample. OSWs and nurses were
asked to identify potential participants on the basis of a range
of ages and geographical spread (urban and rural dwellers
from different locations across the country). They told eligible
patients about the study and provided the study information
sheet and a reply sheet. Then, if the patient indicated they
were potentially willing to participate (returned reply slip), the
OSW/nurse forwarded contact patient details to the interviewer.
The interviewer telephoned patients, answered any questions,
and arranged a suitable time and location for interview. Where
possible this was scheduled to coincide with an outpatient visit.
On the day of the interview, participants were given another
opportunity to ask questions and once these had been
answered satisfactorily, participants were asked to provide
written consent just prior to starting the interview. Throughout
recruitment, the interviewer liaised closely with the health
professionals to maximise variation in the sample. Ethical
approval was provided by the research ethics committee for
each of the participating hospitals. The specific names of the
hospitals and their research ethics committees are not provided
to protect anonymity of the OSWs interviewed.
Interviews
Interviews were conducted in 2007 (OSW interviews:
February-March; patient interviews:
August-September).With the exception of two OSW
interviews, all were face-to-face and audio-recorded (detailed
notes were taken by AT during one face-to-face interview; the
other was conducted by telephone and audio-recorded). OSW
interviews took place at the individuals’ places of work. Patient
interviews took place in a hospital or at a cancer support
centre. Interview questions were structured using a topic guide.
The OSW topic guide was developed from literature review and
the results of analysis of welfare grants provided to patients by
the Irish Cancer Society [27]. The patient topic guide was
developed from literature review and analysis of the OSW
interviews. Both patients and OSWs were asked about:
strategies used to cope with any extra cancer-related costs or
changes in income; impact of extra costs on the family budget
and other aspects of daily life; and anything else they thought
was important. Because OSWs have experience of talking to
large numbers of patients about their financial situation, they
were also asked about particular groups of patients that they
thought were more likely to report the need for financial
adjustments. Patients were asked about their socio-
demographic characteristics and circumstances. Interviews
lasted 30-120 minutes. Interviews were transcribed verbatim,
checked for accuracy, and anonymised.
Analysis
Recruitment to each group of subjects ceased once
saturation was reached [28]. Saturation of data was reached
after 17 OSW interviews and 15 patient interviews since no
new themes or issues related to the topics under investigation
had been reported by the interviewees during the last three
interviews [29]. The remaining 6 OSWs and 5 patients who had
already volunteered were interviewed. No new themes or
issues were reported in these interviews confirming saturation
of data. The OSW and patient interviews were analysed
separately, using a thematic approach [30,31]. This was
ongoing and iterative, such that analysis of early interviews
informed the content of future interviews to ensure sufficient
depth was reached. Analysis was carried out by AT. Three of
the early interview transcripts from each interview set were
coded independently by a second researcher (JM and FD) to
ensure validity of coding categories and analytic rigour. The
codes were compared by AT and found to have very close
agreement and were used in the coding of subsequent
interviews. Atlas.ti software [32] was used to facilitate coding,
link codes and themes across interviews, and consider each
theme in the context of the interview set. Since common
themes arose in the OSW and patient interviews the results are
presented together. Where a theme only arose or was more
strongly emphasised in one or other set of interviews this is
clearly stated. Illustrative quotes are included in figures to
supplement narrative descriptions.
Results
Twenty patients treated in 8 hospitals were interviewed
(Figure 1). Twenty-one OSWs, from
11 hospitals, and with varying levels of experience,
participated. Descriptions of OSWs’ characteristics have been
limited to protect their anonymity. Three major themes relating
to the changes to the financial situation experienced by
patients after a cancer diagnosis were identified: financial
adjustments needed (Figure 2); emotional consequences of
these (financial distress) (Figure 3); and possible risk factors
for financial difficulties and financial distress (Figure 4).
Financial adjustments
All of the patients who stopped working after diagnosis or
during treatment (Figure 1) experienced a drop in income even
after compensatory payments (i.e. sick pay or health/social
welfare benefits). All patients on a reduced income due to
cancer, and patients with a low income pre-diagnosis (e.g.
either earned or through pensions/benefits) found extra cancer-
related costs difficult to manage. Patients and OSW reported
that patients used a range of financial adjustments to try to
cope financially (Figure 2).
Using savings, borrowing, and financial support from
family and friends.  Patients spoke about having to use some
or all of any savings to help cope financially although some,
particularly those with a low pre-diagnosis income, had few
savings. Patients described borrowing money from various
sources including banks/credit unions, employers, family and
friends. Borrowing was often needed for special occasions (e.g.
Christmas). Most patients reported having received some
financial help from family, friends and/or work colleagues; this
Financial Impact of Cancer
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Figure 1.  Characteristics of patients interviewed.  
doi: 10.1371/journal.pone.0077549.g001
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Figure 2.  Financial adjustments.  
doi: 10.1371/journal.pone.0077549.g002
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was not always perceived as “borrowing”, but rather as “help
that was offered”.
Indirect financial support from family and
friends.  Patients often received other types of indirect
financial support from family, friends, neighbours, and
colleagues (e.g. driving to hospital appointments, childcare,
grocery shopping, cooking meals, housework); these reduced
the monetary costs associated with cancer. The security of
Figure 3.  Social and emotional impact of financial burden of cancer.  
doi: 10.1371/journal.pone.0077549.g003
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Figure 4.  Factors increasing financial vulnerability.  
doi: 10.1371/journal.pone.0077549.g004
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having supportive family and friends was commonly spoken
about; those who had support felt fortunate, but questioned
whether it was “right” that they had to rely on this.
Cutting back on household spending.  Patients reported
struggling financially. Difficulties managing the weekly
household budget were common. All patients except two (PT02
and PT10 discussed below) had to budget and spend more
carefully following diagnosis. Strategies used included cutting
back on food shopping; making food last longer; buying
second-hand clothes; turning off heating more; socialising less
often; not going to the hairdresser; reducing spending on
children or “going without” themselves to provide for children;
and not taking short breaks or holidays. Patients reliant solely
on social welfare benefits experienced difficulties managing on
the amount provided (€186/week). Large ongoing expenses
(e.g. treatment-related travel costs, household bills) or one-off
expenses (e.g. a new bed) were especially difficult for these
patients. Some patients (particularly those working at diagnosis
whose income fell) found the financial burden most difficult
soon after diagnosis, whereas others (particularly those on a
low pre-diagnosis income) found it more difficult as time went
on.
Other sources of financial help.  Some patients applied for
means-tested financial assistance. For individual patients who
were struggling financially, OSWs routinely applied for one-off
welfare grants or financial assistance from charities.
Impact on patient care.  OSWs reported sometimes being
asked to help patients who were struggling financially to access
financial assistance to help them comply with treatment.
Examples included patients who were worried about being able
to afford to buy medications or considering stopping treatment
because they could not afford it. The OSWs reported that some
patients (particularly rural patients living a long way from the
treating centre) sometimes had to decide whether they would
sit at home worrying rather than going to their GP about side-
effects of treatment because of cost, or worry about spending
money they couldn’t afford. One OSW described a patient who
had postponed treatment until she received a medical card. A
number of patients described how stressful hospital bills were
while they were waiting for a medical card. None of the patients
interviewed reported making treatment decisions based on
cost/affordability.
Financial distress
OSWs and patients described the emotional impact of the
cancer-related financial impact (i.e. financial distress; Figure 3).
Financial worries.  Medical bills, frequent reviews of
medical card eligibility, and non-medical costs, in particular
travel costs and increased household bills, caused
considerable concern and worry for some patients. Patients
described “scrimping and saving”, “robbing Peter to pay Paul”
and feeling: “terrible”, “miserable”, or “horrible” about finances
as well as feeling “like somebody mean” or “a real miser”. They
described constantly juggling money to avoid getting into debt
and emphasized how worried they were about their financial
situation. Some patients who had stopped working during
treatment were concerned about managing financially on sick
pay and/or benefits. Patients felt that during treatment “their
minds should be focussed on making themselves better and
not worrying about finances”. OSWs reported that patients
were generally uncomfortable with asking for, or accepting
help, particularly from charities, and this caused stress and
worry. They emphasised patient “vulnerability and how difficult
it was for patients “to fight this [obtaining a medical card or
benefits] themselves” after a cancer diagnosis. OSWs reported
trying to help patients reduce financial stress but noted that
because there were so few OSWs they could not help every
patient.
Worries about the future.  As well as being worried about
their current situation, patients described worries about the
future. These included worries about: not being able to
replenish savings used during treatment/illness; implications of
using money saved for retirement or children’s education; and
paying back financial help received from family, friends, or
employers. Younger patients described worrying about making
mortgage payments and their future eligibility for mortgages
and insurance policies. All patients who had been working at
diagnosis expressed work-related concerns including: not
feeling well enough to resume working; worry about returning
to work or looking for a new job after a long absence; and loss
of confidence. Impact of treatment side effects on work ability
was a particular worry and cause of stress for patients who had
developed lymphodema or nerve damage after surgery and
had manual jobs.
Possible risk factors for financial difficulties
OSWs reported that patients in almost any socio-
demographic group could experience financial difficulties,
depending on their particular circumstances and the support
available to them. OSWs identified various possible risk factors
for financial difficulties: working at diagnosis; having young
children; being a lone parent; not having a medical card; low
income pre-diagnosis (earned or through benefits); having
no/few savings; having a mortgage; living in remote/rural areas
without transport; being ineligible for means-tested benefits;
living alone; and lack of family/social support (Figure 4). OSWs
noted that not all patients in these groups experienced financial
difficulties and risk factors often combined to influence patient
vulnerability to cancer-related financial difficulties (e.g. low-
income and few savings; working pre-diagnosis, with children
and a mortgage; elderly with little social support). The patient
experiences mirrored the OSW findings.
In contrast, OSWs reported that various factors could protect
patients from financial difficulties post-cancer: receiving
inpatient treatment; access to hospital accommodation (e.g.
during radiotherapy); supportive family and friends able to
provide financial or practical help; receiving full sick pay; and
having other financial resources (e.g. savings, private health
insurance, illness insurance). Again, combinations of factors
meant that some patients did not have to make any financial
adjustments. For example, a single breast cancer patient
(PT02) received full sick pay, had private health insurance, and
obtained a medical card post-diagnosis. A retired married
prostate cancer patient (PT10) had surgery, few side-effects,
private health insurance, and was eligible for a medical card.
Neither of these patients reported any financial distress.
Financial Impact of Cancer
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Discussion
In the Irish mixed public-private healthcare system, we found
that patients make a wide range of financial adjustments to
cope with out-of-pocket costs and changes in income (financial
burden) they experience post-cancer. Using savings, borrowing
money (both formal and informal), and adjusting the weekly
budget have been reported in a few previous studies in mainly
private or mainly public healthcare settings [4,6,22,33–36]. The
extent of financial adjustments needed varies in all settings but
more extreme measures such a refinancing homes [37] or
house repossessions [23] have been reported in both the US
and the UK. Forgoing treatment or rationing medications
because of cost has been described in other settings [6,38–42]
although Housser et al. [43] recently reported that care-related
cost savings were generally rare among breast and prostate
patients in Canada. In our setting, patients were sometimes
referred to OSWs to avoid this but none of the patients
interviewed reported making treatment decisions based on
cost/affordability. This may reflect the fact that this was
uncommon or the fact that our study was conducted during an
economic boom. As regards more novel findings, borrowing
from employers does not appear to have been reported
elsewhere and may be related to the limited provision of sick
pay in Ireland (and may also apply in other settings where sick
pay provision is scanty). Informal financial support from family
or friends also emerged in a study of colorectal cancer in
Ireland [44]. In our study patients did not always consider this
“borrowing”, which suggests that quantitative studies may
underestimate the prevalence of borrowing money to cope
financially post-cancer.
It is clear from our study, and qualitative research in the UK
and North America [6,22,23,45] that the cancer-related
financial burden and financial adjustments can affect patients
(and their families) emotionally and psychologically. This is
important because cancer-related financial stress (financial
stress experienced post-cancer due to events that are financial
stressors for the household) and financial strain (an individual’s
subjective reactionary perception of financial stress
experienced) have been found to be independent predictors of
psychological well-being post-cancer [46]. Similarly, financial
distress has been reported in cancer patients with health
insurance in the US [37]. Financial distress is itself associated
with negative health effects, including anxiety, insomnia,
headaches and depression [17]. It is possible that financial
distress may extend the duration of cancer’s financial impact by
delaying the time to recovery. Bradley [47] recently highlighted
the need for a better understanding of how financial hardship
varies across patient groups suggesting this might provide
insight into sources of disparity and how they might be
mitigated. Some of the patient characteristics identified by
OSWs as possible risk factors for inadequate financial
protection also emerged from a few studies of other cancers in
other settings. These include: low income [1,5,37,42,48]; being
employed or self-employed [4,49]; being younger [1,7,37,48];
having children [50]; and living in rural areas or further from
treating centre [33,48]. Where our findings extend those from
other studies is that they suggest that it is likely that a
combination of risk factors operate together to influence
financial protection - either negatively or positively. The latter is
important in better understanding what may protect patients
from financial difficulties post-cancer.
Implications for financial protection in health
Clearly in addition to patients’ individual circumstances (e.g.
availability of savings/assets, financial support from family/
friends) and the financial compensation and protection
provided by the public or private components of the healthcare
system, the legal and social welfare system where patients live
is also important in influencing the financial impact of having
cancer. However, despite international variations in healthcare,
legal and social welfare systems, our findings add to those
from elsewhere [5,23,39,40] to suggest that – in all (or, at least,
almost all) settings - some cancer patients need to make
financial adjustments and have inadequate financial protection
post-cancer. Furthermore, findings from the current study point
to the fact that the financial impact of cancer, and inadequate
financial protection, affects the whole family unit and not just
the patient themselves. Several authors have called for more
sensitive and standardised ways of capturing cancer or illness-
related costs to patients and families [15,47,51]. Financial
adjustments and financial distress are rarely considered in
formal assessments of the financial/economic impact of cancer
either in research or the practice/clinical setting. Nor are they
included in conventional frameworks for analysing financial
protection in health. Both Moreno-Serra et al. [15] and Ruger
[20] have recently suggested that current measures of the
consequences of inadequate financial protection are too
narrow and probably underestimate the adverse consequences
of inadequate financial protection in health. Ruger [20] has
proposed an alternative multidimensional approach using a
“financial protection profile” to better reflect how individuals and
households cope financially after confronting a health need.
Our findings reported here and elsewhere [9] also highlight the
need for more comprehensive metrics to assess financial
protection in health, which we suggest should include: out-of-
pocket direct medical and non-medical costs; changes in
income (which are not included in Ruger’s financial protection
profile); financial adjustments (including coping strategies and
household consumption patterns as per Ruger); and financial
distress (not included by Ruger).
Implications for financial information and advice
services
The need for financial assessment, information, and advice
intermittently throughout the cancer journey has been
highlighted both in Ireland and the UK [9,52,53]. In the UK,
Moffatt et al. [54], recently demonstrated the benefits of a
welfare rights advice intervention designed to address the
financial consequences of cancer. Importantly, in that study,
and in a US study on the effects of participation in a debt
management programme [17], as well as financial benefits,
these initiatives resulted in positive social and psychological
consequences; this suggests that interventions aimed at
alleviating financial burden and adjustments post-cancer may
also alleviate financial distress.
Financial Impact of Cancer
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Strengths and limitations
The use of explorative qualitative methods has improved
understanding of the complex financial adjustments cancer
patients use to cope with their financial situation and,
importantly, the consequences of these (i.e. financial distress).
Data of such richness and depth would not have been available
using a quantitative approach. While it is not possible to
estimate the proportion of cancer patients with financial
difficulties that discussed their financial situation with an OSW,
the inclusion of 87% of the OSWs in the country who
collectively have assisted large numbers of cancer patients
over many years, corroborated the information from the patient
interviews, and provided valuable additional insight into the
predictors of financial adjustments and financial distress. This
important “bigger picture” would not have been evident from
patient interviews alone. Moreover, our results extend the
existing evidence-base on the financial effects of cancer by
adding data from a mixed public-private healthcare system.
The fact that the healthcare systems in most countries are
based on a combination of libertarian (private) and egalitarian
(public) ideologies [21] suggests that the results of this study
may have broader implications for other jurisdictions. We
explicitly included patients who had reported experiencing
“extra costs” or “financial difficulties” due to cancer and this
enabled us to capture the multidimensional aspects of the
financial impact. To achieve a maximum variation patient
sample we relied on OSWs and oncology nurses to identify
potential participants, using stratification based on gender, age,
employment status, cancer type, and residence. While
professionals’ role in identification of participants was critical to
ensure that sharing of patient information with the researcher
team took place on an ‘opt-in’ basis (in line with good practice),
this did mean that there was a possibility that professionals
selected those patients who they thought would represent
particular perspectives. While it is certainly possible that
professionals were thoughtful about their selection of patients,
the researcher discussed with them the need for a diverse
sample prior to and during the recruitment process. In addition,
the credibility of the research processes, including the
sampling, is evidenced by the varied experiences and opinions
contained in the dataset as a whole.
Conclusions
Both patients and OSWs reported that some patients need to
make financial adjustments in order to cope financially after a
cancer diagnosis. A broad range of financial adjustments were
reported and included: using savings (if any); formal and
informal (from family and friends) borrowing (if available);
budgeting very carefully; and cutting back on weekly household
spending. Moreover, financial distress is a common outcome of
cancer-related out-of-pocket costs, lost income and these
financial adjustments. Our findings add to an accumulating
evidence-base which implies that the different types of
healthcare system (mixed public/private, mainly public, and
mainly private) may not provide financial protection for patients
and families post-cancer. To advance understanding, and
inform development of effective strategies, interventions or
policies, there is a need for a broader and more comprehensive
set of metrics to measure financial protection in health; these
should include consideration of financial adjustments and
financial distress. In the meantime, patients and their families
should be offered financial information and advice intermittently
throughout the cancer journey.
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